Physician

Andrew Joseph Mcclellan, MD

According to 2025 Medicare claims, Andrew Mcclellan, MD (NPI: 1588935217) practices ophthalmology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS RETINA ASSOCIATES (NPI: 1851300792; TIN: 751362336) and primary practice location at 76104-4306. Mcclellan is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Mcclellan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,180 traditional Medicare patients, billed 73,762 HCPCS/CPT codes, and received $5,227,046 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 664 prescription claims across 263 beneficiaries totaling $41,003 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 18 records totaling $1,352. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,006 to $5,227,046. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $10,291 to $41,003. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.